Apselan

Quick links to important sections

Apselan

Method of action: Antitussive, Nasal Preparations

Treatment option: Blocked Nose, Cold

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Apselan

Quick Facts: Apselan Identity

Property Description
Active ingredient Pseudoephedrine hydrochloride
Form Oral tablet, extended-release capsule, liquid/syrup
Pharmacological class Sympathomimetic amine, Adrenergic agent
Common use Relief of nasal and sinus congestion
Origin Synthetic compound

Pharmacological Identity and Composition

Apselan is a pharmaceutical preparation whose primary active constituent is Pseudoephedrine hydrochloride, classified as an oral systemic decongestant. Pharmacologically, it belongs to the class of sympathomimetic amines and acts as an adrenergic agent designed to alleviate congestion through a systemic route. Pseudoephedrine is generally used for the temporary relief of nasal congestion caused by the common cold, allergies, and hay fever. This clinical application indicates that the primary benefit of this medicine is to ease breathing difficulty caused by seasonal or acute respiratory blockage.

Apselan’s active core is the synthetic compound Pseudoephedrine, which structurally relates to the alkaloid Ephedrine. It is most frequently a single-ingredient product, though it may appear in combination formulations. Its forms are suited for the oral route of administration, including standard tablets and specific extended-release capsules designed to provide sustained relief.

General Therapeutic Purpose

The fundamental purpose of Apselan is rooted in its ability to manage the uncomfortable symptoms of nasal and sinus congestion. The drug's action causes a vasoconstriction (narrowing) of the blood vessels within the membranes lining the nose and sinuses, reducing the accumulation of fluid and tissue swelling.

Decongestants like Pseudoephedrine function to relieve the symptoms of a blocked nose, which helps restore clear breathing. The preparation's utility lies in restoring the clear function of the nasal airways and drainage paths in situations such as upper respiratory infection or allergic episodes.

Regulatory References

  1. Pseudoephedrine: MedlinePlus Drug Information
  2. Pseudoephedrine-containing medicinal products - referral

What side effects are possible with Apselan?

Apselan is associated with both common and serious, but rare, adverse reactions, as documented in regulatory safety summaries. The safety profile highlights particular risks related to cardiovascular and nervous system effects.

Adverse Reaction Categories

Classification Examples of Documented Reactions
Common Dry mouth, nausea, dizziness, nervousness, and insomnia.
Serious / Rare Posterior Reversible Encephalopathy Syndrome (PRES), Reversible Cerebral Vasoconstriction Syndrome (RCVS), Colitis, and Acute Generalized Exanthematous Pustulosis (AGEP).

Serious reactions, such as PRES and RCVS, involve conditions that can reduce blood supply to the brain, and while rare, require immediate medical attention if symptoms occur. Other serious reactions include sudden vision loss, potentially due to decreased blood flow in the optic nerve, and severe skin reactions like fever with generalized redness and pustular rash.

Safety Restrictions and Monitoring

Apselan is formally contraindicated in patients with severe or uncontrolled high blood pressure and those with severe acute or chronic kidney disease or failure, as these conditions are established risk factors for PRES and RCVS. The medicine should also not be used in children under 12 years of age. Caution is required in patients with pre-existing conditions such as heart disease, diabetes, hyperthyroidism, or increased intraocular pressure.

Patients are advised in official regulatory texts to discontinue the medicine immediately and seek urgent medical assistance if they experience signs of a serious reaction, including sudden severe headache, confusion, seizures, or changes in vision.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents specify that an overdose of Apselan (Pseudoephedrine hydrochloride) is associated with severe central nervous system (CNS) and cardiovascular effects. Documented overdose presentations often include signs of CNS hyperexcitation such as convulsions (seizures), tremor, hallucinations, confusion, and extreme restlessness. Cardiovascular manifestations involve tachycardia (fast, pounding heartbeat), irregular heartbeat, and severe hypertension (dangerously high blood pressure).

Severe or life-threatening outcomes cited in regulatory labeling include intracranial haemorrhage and myocardial infarction (heart attack), which may progress to cardiovascular collapse. Immediate medical assistance is required if the victim exhibits a seizure, trouble breathing, or signs of dangerously high blood pressure.

Official instructions mandate that in case of overdose, the user must seek immediate medical help or contact a Poison Control Center right away. Management, as described in regulatory text, is symptomatic and supportive, as no specific antidote is known. The official labeling notes that in children, drowsiness has been specifically reported as an overdose manifestation.

Therapeutic Uses of Apselan

Quick Facts: What Apselan Treats

  • Nasal and Sinus Congestion: May help relieve the symptoms of a blocked or stuffy nose.
  • Associated Conditions: Is used for the management of nasal inflammation linked to the common cold, influenza, and allergic rhinitis.

Apselan is utilized for the symptomatic relief of nasal and paranasal sinus inflammation. Its primary role is to support the clearance of nasal congestion and reduce related discomfort experienced during the course of certain respiratory illnesses or allergic reactions. The medication may contribute to the reduction of upper respiratory tract mucosal swelling, including that of the nasal mucosa and paranasal sinuses.

This therapeutic approach is suitable for managing symptoms associated with the common cold, flu, and allergic rhinitis. Its benefits include helping to maintain the natural flow and function of the nasal airways. For a detailed description of approved uses and safety information, patients should consult official product labeling or patient information leaflets. A healthcare professional is the correct resource for guidance on individual treatment plans and dosages.

Regulatory References

  1. EMA therapeutic overview

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility Status

Regulatory labeling establishes specific population groups who are eligible, restricted, or strictly prohibited from using Apselan (Pseudoephedrine).

Classification Population/Condition Regulatory Status
Eligible Adults and children aged 12 years and over (for single-ingredient products). Allowed
Contraindicated Patients with severe hypertension or severe coronary artery disease. Prohibited
Contraindicated Patients receiving Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of cessation. Prohibited
Contraindicated Patients with narrow angle glaucoma or urinary retention. Prohibited
Restricted Age Children under 6 years of age. Not Recommended/Contraindicated
Conditional Use Patients with diabetes mellitus, hyperthyroidism, or prostatic enlargement. Caution Required
Conditional Use Patients with severe renal or hepatic impairment. Caution Required
Reproductive Status Women who are pregnant (especially first trimester) or breastfeeding. Not Recommended

Eligibility is primarily determined by pre-existing cardiovascular risk and the use of certain medications (MAOIs). The use of Apselan is strictly prohibited for groups with severe, specific coexisting conditions. For all others requiring caution, use is subject to evaluation of the condition's stability and severity, as dictated by official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Apselan (Pseudoephedrine hydrochloride) has formally documented interaction patterns primarily concerning its effects as a sympathomimetic amine, as consistently defined by regulatory agencies.


Contraindicated Combinations and Administration Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated due to the high risk of a severe hypertensive crisis. Official labeling mandates a minimum 14-day separation period after stopping MAOI therapy before starting Apselan. The drug is also contraindicated for co-use with other sympathomimetic agents (e.g., decongestants, appetite suppressants) due to the risk of additive pressor effects.

Pharmacodynamic and Exposure Interactions

Concomitant use with certain medications may result in documented pharmacodynamic effects. For instance, Apselan may officially antagonize the blood pressure-lowering action of various antihypertensive agents (including beta-blockers and methyldopa). Combination with Tricyclic Antidepressants (TCAs) may increase the risk of elevated blood pressure. Furthermore, co-administration with Halogenated Anaesthetic Agents (e.g., halothane) is documented to increase the risk of ventricular arrhythmias.

Regarding drug exposure, substances that are urinary alkalinisers are officially noted to decrease the elimination rate of Pseudoephedrine, which can lead to an increased plasma half-life. Patients with severe or uncontrolled hypertension or severe renal impairment are noted in labeling as having an increased risk for severe interaction outcomes.

Mechanism of Action

How Apselan Works: Mechanism of Action

Apselan's primary activity is based on sympathomimetic agonism directed at the alpha1-adrenergic receptors located on vascular smooth muscle, predominantly within the nasal and paranasal sinus mucosa. Binding to these receptors initiates the intracellular Gq signaling cascade, which culminates in an increase in free intracellular Ca^2+ levels. This increase in calcium concentration drives the contraction (vasoconstriction) of the local blood vessels.

The resulting physiological consequence is a reduction in local blood flow and, subsequently, a decrease in mucosal tissue volume.

However, this mechanism is subject to dynamic limitations: prolonged or repeated receptor stimulation can lead to desensitization (tachyphylaxis). This process reduces the alpha1 receptors' responsiveness, thus limiting the sustained ability of the drug to induce vasoconstriction and determining the duration of the physiological change in mucosal volume.

Dosage and Administration Information

Apselan (Pseudoephedrine hydrochloride) is approved for administration exclusively via the oral route, utilizing dosage forms such as immediate-release tablets, extended-release caplets (e.g., 120 mg, 240 mg), and liquid solutions. The usage protocol is structured around the formulation type, dictating fixed dose frequency and total daily intake limits.

Standardized Dosing and Frequency

Formulation Type Single Dose (Adults ge12) Frequency Max Daily Dose
Immediate-Release (IR) 30 mg to 60 mg Every 4 to 6 hours 240 mg
12-Hour Extended-Release 120 mg Every 12 hours 240 mg
24-Hour Extended-Release 240 mg Once daily 240 mg

The standard protocol defines use for short-term courses, with self-medication generally limited to a period of up to seven consecutive days. The total intake must not exceed the maximum daily dose of 240 mg over any 24-hour interval. For pediatric use, the total maximum daily dose for children aged 6 to 11 years is capped at 120 mg, and use is not authorized for children under six years of age.

Administration Rules and Procedural Constraints

The medication can be taken without a specific requirement for food intake. Extended-release forms must not be divided, crushed, chewed, or dissolved; they must be swallowed whole to preserve the designed drug release pattern. For oral liquid formulations, an accurate, calibrated measuring device should be used for precise dose measurement. Additionally, immediate-release doses should be timed to be administered several hours prior to bedtime. Caution is advised, and dosage adjustment is necessary in cases of severe renal or severe hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Apselan


Evidence for Use in Common Cold Congestion

Research for Apselan (pseudoephedrine) primarily uses short-term, randomized controlled trials (RCTs). These studies compared the patterns observed in participants randomly assigned to receive either the medicine or a placebo (a dummy pill). Research examined how the medicine was associated with changes measured during the study period in both patient-reported congestion intensity and objective outcomes, such as nasal airflow. Studies examined patient-reported outcomes describing perceived discomfort. Findings describe differences in congestion measurements that were observed between the study groups over the observation period.

Systematic reviews, which combine data from many trials, described observed statistical differences. However, the overall magnitude of this observed change is sometimes characterized as small in clinical terms. The research has mostly focused on short-term symptom changes over a few hours or, at most, a few days. Evidence is limited regarding the long-term impact on a person’s overall daily functioning.


Evidence for Use in Allergic Rhinitis and Specialized Uses

Apselan was studied for its use in managing nasal congestion that occurs during allergic reactions (Allergic Rhinitis). These studies often involved controlled trials where participants with diagnosed allergies were monitored. Research also examined outcomes in studies focusing on otic barotrauma, which is the temporary discomfort that occurs in the ear during rapid pressure changes (e.g., during air travel).

Clinical trials focusing on barotrauma reported that individuals receiving the medication showed differences in the incidence and severity of reported ear symptoms compared to those receiving placebo during and immediately after the pressure event. However, sample sizes were modest in these specialized trials, meaning the results apply only to the populations studied and may not be broadly generalized.

Data for certain groups remain insufficient when looking specifically at Apselan alone over long time frames. Furthermore, long-term effects are not fully established, and the existing evidence does not contribute significantly to understanding patterns related to extended use.

Key Studies & References

  1. A Multicenter, Randomized, Placebo-Controlled Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold
  2. Pseudoephedrine Prophylaxis for Prevention of Middle Ear Barotrauma in Hyperbaric Oxygen Therapy (Trial Protocol)
  3. Pseudoephedrine: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Apselan (FAQ)


Q: Is Apselan considered a long-term or short-term medication?

Official guidance indicates that medicines containing pseudoephedrine are generally intended for short-term courses for the temporary relief of symptoms. Use is often described as limited to a period of up to seven consecutive days for non-prescription use, according to official regulatory documentation.


Q: What happens if I forget to take Apselan?

If a dose is missed, patient instructions advise taking the next dose when needed, provided the minimum time interval between doses is maintained. Regulatory documents state that a double dose should not be taken to make up for a missed dose.


Q: Can Apselan cause weight gain or weight loss?

Weight loss is not commonly documented in the adverse reaction profile. However, loss of appetite has been noted as a less common side effect in some product information. Weight gain is not typically listed as a documented adverse reaction in official safety summaries.


Q: Does Apselan interact with blood pressure medication?

Yes, regulatory documents note that Apselan can act as a vasoconstrictor, which is an effect that may be associated with increased heart rate and blood pressure. It is documented to antagonize the blood pressure-lowering action of various antihypertensive agents.


Q: Are there any vitamins or supplements that interact with Apselan?

Regulatory warnings indicate that patients should discuss the use of all medicines, vitamins, minerals, herbal products, and supplements with a healthcare provider, as many may have documented or unknown interaction patterns. This information is key for a provider to assess the overall safety profile.


Q: What happens if I suddenly stop taking Apselan?

Abrupt discontinuation after appropriate use is typically not associated with severe effects. However, regulatory labeling lists Drug Dependence as a potential risk with misuse or high-dose, extended use. In contexts of misuse, abrupt cessation has been associated with certain temporary physical or psychological effects.


Q: Is it possible to become dependent on Apselan?

Because the active ingredient in Apselan is chemically related to other stimulants, regulatory labels acknowledge that Drug Dependence is a potential risk. This is noted particularly when the medicine is misused or taken for periods longer than officially recommended.


Q: Does taking Apselan require a specific diet?

Official administration rules state the medication can be taken without a specific requirement for food. However, as Apselan is a stimulant, official guidance recommends limiting the intake of caffeine, as this may intensify stimulant-like side effects like nervousness and difficulty sleeping.


Q: How long has Apselan been on the market?

The active compound in Apselan, Pseudoephedrine, has a long history in pharmaceutical use. Its decongestant effects were first described in scientific literature as far back as 1927, indicating its long-standing presence in medicine.


Q: How is Apselan different from other treatments used for the same condition?

Apselan is classified as a sympathomimetic amine. Studies have examined observed differences in effectiveness and mechanism of action compared to other decongestants, such as phenylephrine, in the temporary relief of congestion.


Q: Can Apselan be used for conditions other than its approved uses?

The official, approved use of Apselan is strictly for the temporary relief of nasal and sinus congestion related to the common cold or allergies. Regulatory documents do not recommend or describe the use of the medicine outside of this approved scope.


Q: Are the side effects of Apselan permanent?

Common side effects are generally described in regulatory texts as temporary. While serious and rare adverse reactions are documented, even those involving changes to blood supply, such as PRES and RCVS, are defined as having the potential to be reversible.


Q: How quickly does Apselan typically start working?

The onset of action for the active ingredient is typically rapid. Regulatory-aligned information indicates that effects usually begin to be observed within 15 to 30 minutes following administration.


Q: How long does the effect of one dose of Apselan last?

The duration of relief depends on the specific formulation type. Immediate-release forms provide symptom relief for approximately 4 to 6 hours, while the extended-release forms are designed to sustain their effect over 12 or 24 hours, corresponding to the prescribed frequency.


Q: Does Apselan need to be taken at the same time every day?

This medication is usually taken only as needed for symptoms. If a regular schedule is indicated by a healthcare provider, a consistent dosing schedule is generally used. This helps ensure sustained relief while adhering to maximum daily dose limits.


Q: Can Apselan interact with caffeine?

Yes, official guidance often recommends limiting the intake of substances containing caffeine (such as coffee, certain teas, or chocolate). This is because combining the two may increase the risk of stimulant-related side effects like nervousness and a fast heartbeat.


Q: Can Apselan affect my ability to drive or operate machinery?

Official warnings advise avoiding activities that require complete mental alertness, such as driving or operating heavy machinery, until the individual is aware of how the medicine affects them. This is due to the risk of common side effects like dizziness or difficulty sleeping.


Q: Why are there different strengths of Apselan available?

The various strengths available (e.g., 30 mg, 60 mg, 120 mg, 240 mg) are designed to support different treatment needs. These strengths correspond to different formulation types, such as immediate-release versus extended-release, and help meet the specific dosing requirements for different age groups as outlined in official monographs.


Q: Is Apselan used for pain relief?

No, Apselan (pseudoephedrine) is officially classified as a systemic decongestant. Its documented purpose is to relieve nasal and sinus congestion. It does not have an approved indication as a primary pain reliever.


Q: Does Apselan affect my mood or sleep?

Yes, the medication can affect the central nervous system. Common side effects listed in official safety summaries include nervousness, restlessness, and difficulty sleeping (insomnia).


Q: What is the risk of an allergic reaction to Apselan?

The risk of a severe allergic reaction is documented in the official safety sections. In the event signs of a serious reaction are experienced, such as facial swelling, hives, or trouble breathing, regulatory documents specify that immediate medical attention should be sought.


Q: Is it okay to crush or split Apselan tablets?

Official administration rules state that extended-release tablets must be swallowed whole to preserve the drug's designed release pattern. They should not be crushed, chewed, or split unless explicitly advised by a healthcare professional and the tablet has a score line.


Q: Is the effectiveness of Apselan consistent across all patient groups?

Clinical trial research indicates that the measured effectiveness of Apselan may show some variability, and efficacy data is often limited in specific patient subgroups. Studies have noted that effectiveness data is often limited in specific patient subgroups, such as children under 12.


Q: Can Apselan make my existing condition worse?

Yes, official labeling states the medicine is contraindicated or requires extreme caution in patients with severe pre-existing conditions. Official labeling notes that the medicine may worsen conditions such as severe or uncontrolled high blood pressure or certain heart diseases, and is therefore contraindicated or requires extreme caution in these patient populations.


Q: What is the meaning of the chemical name of Apselan?

The active ingredient, Pseudoephedrine hydrochloride, is named according to its chemical structure. It is part of the phenylethanolamines class of compounds and is an isomer (structural variant) of the compound ephedrine, which indicates its systemic decongestant function.


Q: Is it safe to take Apselan with over-the-counter pain relievers?

Regulatory guidance advises caution regarding co-administration. Since Apselan is a sympathomimetic agent, combining it with other medicines—even over-the-counter ones—may lead to additive side effects, particularly those affecting the cardiovascular system.

How should Apselan be stored and disposed of?

How to Store and Dispose of Apselan?

The storage and disposal of Apselan (Pseudoephedrine hydrochloride) must strictly adhere to regulatory labeling to maintain stability and ensure safety.

Official Storage Requirements

Apselan must be kept at room temperature, typically defined as 20 C to 25 C (68 F to 77 F). To maintain chemical integrity, the medication must be stored in the original container, kept tightly closed, and protected from excess heat and moisture.

Child Safety: It is a mandatory requirement to store Apselan out of the sight and reach of children and to keep the container secured, often specified as store locked up.

Official Disposal Instructions

Unused or expired Apselan must be disposed of in accordance with local regulations, often utilizing community drug take-back programs. Official guidelines emphasize that the product must not be allowed to enter the sewage system or surface water, and should not be disposed of with general household trash unless the local program directs otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Apselan found in:

A-Z Index: